A longitudinal comparative analysis of serum metabolomic signatures in children with SARS-CoV-2 infection and MIS-C

Posted on
a-longitudinal-comparative-analysis-of-serum-metabolomic-signatures-in-children-with-sars-cov-2-infection-and-mis-c
A longitudinal comparative analysis of serum metabolomic signatures in children with SARS-CoV-2 infection and MIS-C

References

  1. Ludvigsson, J. F. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 109, 1088–1095 (2020).

    Google Scholar 

  2. Girona-Alarcon, M. et al. The different manifestations of COVID-19 in adults and children: a cohort study in an intensive care unit. BMC Infect. Dis. 21, 87 (2021).

    Google Scholar 

  3. Garazzino, S. et al. Epidemiology, clinical features and prognostic factors of pediatric SARS-CoV-2 infection: results from an Italian multicenter study. Front. Pediatr. 9, 649358 (2021).

    Google Scholar 

  4. Rhedin, S. et al. Risk factors for multisystem inflammatory syndrome in children-a population-based cohort study of over 2 million children. Lancet Reg. Health Eur. 19, 100443 (2022).

    Google Scholar 

  5. Stephenson, T. et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc. Health 6, 230–239 (2022).

    Google Scholar 

  6. Shen, B. et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell 182, 59–72 (2020).

    Google Scholar 

  7. Thaker, S. K., Ch’ng, J. & Christofk, H. R. Viral hijacking of cellular metabolism. BMC Biol. 17, 59 (2019).

    Google Scholar 

  8. Allen, C. N. S., Arjona, S. P., Santerre, M. & Sawaya, B. E. Hallmarks of metabolic reprogramming and their role in viral pathogenesis. Viruses 14, 602 (2022).

    Google Scholar 

  9. Hoxha, M. What about COVID-19 and arachidonic acid pathway? Eur. J. Clin. Pharm. 76, 1501–1504 (2020).

    Google Scholar 

  10. Blasco, H. et al. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism. Sci. Rep. 10, 16824 (2020).

    Google Scholar 

  11. San Juan, I. et al. Abnormal concentration of porphyrins in serum from COVID-19 patients. Br. J. Haematol. 190, e265–e267 (2020).

  12. Pang, Z., Chong, J., Li, S. & Xia, J. MetaboAnalystR 3.0: toward an optimized workflow for global metabolomics. Metabolites 10, 186 (2020).

    Google Scholar 

  13. Wang, C. et al. Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19. Theranostics 11, 8008–8026 (2021).

    Google Scholar 

  14. Centers for Disease Control and Prevention. Emergency Preparedness and Response: Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19) https://emergency.cdc.gov/han/2020/han00432.asp (2020).

  15. Troisi, J. et al. Metabolomic signature of endometrial cancer. J. Proteome Res. 17, 804–812 (2018).

    Google Scholar 

  16. Wold, S., Sjöström, M. & Eriksson, L. Partial least squares projections to latent structures (PLS) in chemistry. in (eds von Ragué Schleyer, P. et al.) Encyclopedia of Computational Chemistry (John & Wiley Sons, 1998).

  17. Sysi-Aho, M. et al. Normalization method for metabolomics data using optimal selection of multiple internal standards. BMC Bioinform. 8, 93 (2007).

    Google Scholar 

  18. Kuhn, M. Building predictive models in R using the caret package. J. Stat. Softw. 28, 1–26 (2008).

    Google Scholar 

  19. Szymańska, E., Saccenti, E., Smilde, A. K. & Westerhuis, J. A. Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies. Metabolomics 8, 3–16 (2012).

    Google Scholar 

  20. Domingos, P. MetaCost: a general method for making classifiers cost-sensitive. In Proc. Fifth ACM SIGKDD International Conference Knowledge Discovery and Data Mining 155–164 (ACM, 1999).

  21. Sumner, L. W. et al. Proposed minimum reporting standards for chemical analysis chemical analysis working group (CAWG) metabolomics standards initiative (MSI). Metabolomics 3, 211–221 (2007).

    Google Scholar 

  22. Xia, J. & Wishart, D. S. MetPA: a web-based metabolomics tool for pathway analysis and visualization. Bioinformatics 26, 2342–2344 (2010).

    Google Scholar 

  23. Pellegrino, R., Chiappini, E., Licari, A., Galli, L. & Marseglia, G. L. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur. J. Pediatr. 181, 3995–4009 (2022).

    Google Scholar 

  24. Chiu, C. Y. et al. Metabolomics reveals dynamic metabolic changes associated with age in early childhood. PLoS ONE 11, e0149823 (2016).

    Google Scholar 

  25. Pang, Z., Zhou, G., Chong, J. & Xia, J. Comprehensive meta-analysis of COVID-19 global metabolomics datasets. Metabolites 11, 44 (2021).

    Google Scholar 

  26. García, L. F. Immune response, inflammation, and the clinical spectrum of COVID-19. Front. Immunol. 11, 1441 (2020).

    Google Scholar 

  27. Firpo, M. R. et al. Targeting polyamines inhibits coronavirus infection by reducing cellular attachment and entry. ACS Infect. Dis. 7, 1423–1432 (2021).

    Google Scholar 

  28. Sacco, K. et al. Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat. Med. 28, 1050–1062 (2022).

    Google Scholar 

  29. Teoh, S. T. et al. Combined plasma and urinary metabolomics uncover metabolic perturbations associated with severe respiratory syncytial viral infection and future development of asthma in infant patients. Metabolites 12, 178 (2022).

    Google Scholar 

  30. Bozzetto, S. et al. Metabolomic profile of children with recurrent respiratory infections. Pharm. Res. 115, 162–167 (2017).

    Google Scholar 

  31. Wang, Y. et al. Blood transcriptome responses in patients correlate with severity of COVID-19 disease. Front. Immunol. 13, 1043219 (2023).

    Google Scholar 

  32. Nagao-Kitamoto, H. & Kamada, N. Host-microbial cross-talk in inflammatory bowel disease. Immune Netw. 17, 1–12 (2017).

    Google Scholar 

  33. Storr, M., Vogel, H. J. & Schicho, R. Metabolomics: is it useful for inflammatory bowel diseases? Curr. Opin. Gastroenterol. 29, 378–383 (2013).

    Google Scholar 

  34. Lin, H. M., Helsby, N. A., Rowan, D. D. & Ferguson, L. R. Using metabolomic analysis to understand inflammatory bowel diseases. Inflamm. Bowel Dis. 17, 1021–1029 (2011).

    Google Scholar 

  35. Sperisen, P., Cominetti, O. & Martin, F. P. Longitudinal omics modeling and integration in clinical metabonomics research: challenges in childhood metabolic health research. Front. Mol. Biosci. 2, 44 (2015).

    Google Scholar 

  36. Carroll, M. W. et al. The impact of inflammatory bowel disease in Canada 2018: children and adolescents with IBD. J. Can. Assoc. Gastroenterol. 2, S49–S67 (2019).

    Google Scholar 

  37. Sindelar, M. et al. Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. Cell Rep. Med. 2, 100369 (2021).

    Google Scholar 

  38. Maeda, R. et al. Amino acid catabolite markers for early prognostication of pneumonia in patients with COVID-19. Nat. Commun. 14, 8469 (2023).

    Google Scholar 

  39. Pratomo, I. P. et al. Xanthine oxidase-induced inflammatory responses in respiratory epithelial cells: a review in immunopathology of COVID-19. Int J. Inflamm. 2021, 1653392 (2021).

    Google Scholar 

  40. Pol, K., Puhlmann, M. L. & Mars, M. Efficacy of L-arabinose in lowering glycemic and insulinemic responses: the modifying effect of starch and fat. Foods 11, 157 (2022).

    Google Scholar 

  41. Ahmed, I., Roy, B. C., Khan, S. A., Septer, S. & Umar, S. Microbiome, metabolome and inflammatory bowel disease. Microorganisms 4, 20 (2016).

    Google Scholar 

  42. Ursell, L. K. et al. The intestinal metabolome: an intersection between microbiota and host. Gastroenterology 146, 1470–1476 (2014).

    Google Scholar 

  43. Teufel, R. et al. Bacterial phenylalanine and phenylacetate catabolic pathway revealed. Proc. Natl. Acad. Sci. USA 107, 14390–14395 (2010).

    Google Scholar 

  44. Sperling, O. Human purine metabolism. in (eds De Jong, J.W.) Myocardial Energy Metabolism, Vol 91 (Springer, 1988).

  45. Farley S. E. et al. A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants. Nat. Commun. 13, 3487 (2022).

  46. Van Wyngene, L., Vandewalle, J. & Libert, C. Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last? EMBO Mol. Med. 10, e8712 (2018).

    Google Scholar 

  47. Niu, Z. et al. Circulating glycerolipids, fatty liver index, and incidence of type 2 diabetes: a prospective study among Chinese. J. Clin. Endocrinol. Metab. 106, 2010–2020 (2021).

    Google Scholar 

  48. Prentki, M. & Madiraju, S. R. Glycerolipid metabolism and signaling in health and disease. Endocr. Rev. 29, 647–676 (2008).

    Google Scholar 

  49. Hofer, S. J. et al. Mechanisms of spermidine-induced autophagy and geroprotection. Nat. Aging 2, 1112–1129 (2022).

    Google Scholar 

  50. Danlos et al. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers. Cell Death Dis. 12, 258 (2021).

    Google Scholar 

  51. Korbecki, J. & Bajdak-Rusinek, K. The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms. Inflamm. Res. 68, 915–932 (2019).

    Google Scholar 

Download references

Related Posts